01 diciembre 2014

CVIR. Uterine Artery Embolization for Symptomatic Leiomyomata

Hans van Overhagen, Jim A. Reekers

Transcatheter uterine artery embolization (UAE) for treatment of fibroids was first reported by Ravina in 1995. The continuous advance in the field of vascular Interventional Radiology has facilitated UAE, through the development of low profile catheters and particulate emboli such as polyvinyl alcohol particles (PVA), PVA microspheres and tris-acryl gelatine microspheres (TAGM). Prospective randomized studies such as the EMMY and REST trial that compare UAE with hysterectomy have proven scientifically that there is a place for UAE in the treatment of women with symptomatic fibroids. The QOL 5 years after hysterectomy or embolization is equal. Several registries and non-randomized trials have supported these findings. The trials have shown that UAE should be offered to women with symptomatic fibroids causing menorrhagia, as an alternative to hysterectomy (Level 1). The present document provides quality assurance guidelines regarding UAE for the treatment of symptomatic uterine fibroids.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Yvonne Bausback, MD; Josef Friedenberger, MD; Klaus Hertting, MD; Martin Werner, MD; Daniela Branzan, MD; Bruno Freitas, MD; Michael Piorkowski, MD; Andrej Schmidt, MD; Dierk Scheinert, MD

Purpose: To investigate the effect of renal denervation (RDN) on blood pressure and renal function in refractory hypertension after renal artery recanalization and optimal medical therapy.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Is an Abnormal Vascular Response After Renal Sympathetic Denervation Predictive of Permanent Damage?: An Unusual Case of Late Renal Artery Stenosis After Energy Delivery

Francesco Versaci, MD; Antonio Trivisonno, MD; Carlo Olivieri, MD; Gianludovico Magri, MD; Fiorella Caranci, MD; Francesco Prati, MD

Percutaneous renal sympathetic denervation (RDN) is a very promising treatment strategy adopted to supplement antihypertensive therapy in patients with resistant hypertension. Despite the widespread performance of this procedure, serious complications during the procedure have not yet been reported. We report a case of transient renal artery stenosis during RDN complicated by late stenosis.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Transcatheter Renal Sympathetic Denervation for Resistant Arterial Hypertension: When Sham Brings Shame?

Giuseppe Biondi-Zoccai, MD; Mariangela Peruzzi, MD, PhD; Arturo Giordano, MD, PhD; Giacomo Frati, MD

Patients with arterial hypertension responding suboptimally to drug treatment (i.e., those with resistant hypertension) represent a sizable group and a clinical challenge. Building upon prior favorable evidence for surgical renal sympathetic denervation and experimental data underlying the detrimental impact of the sympathetic nervous system on blood pressure control, transcatheter renal sympathetic denervation (TRSD) has been recently introduced into clinical practice. This procedure has been demonstrated safe and effective in reducing systolic and diastolic blood pressure in patients with resistant hypertension based on non-blinded randomized clinical trials, observational studies, and anecdotal cases. This evidence has led to approval of the devices in Europe and other countries, but not yet in the US, India, or Japan. Indeed, thousands of patients have already been treated with this procedure, with apparently satisfactory outcomes.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Evaluation of Visceral Artery Displacement by Endograft Delivery System Insertion

Blandine Maurel, MD, PhD; Adrien Hertault, MD; Teresa Martin Gonzalez, MD; Jonathan Sobocinski, MD, PhD; Marielle Le Roux, MD; Jessica Delaplace, MD; Richard Azzaoui, MD; Marco Midulla, MD, PhD; Stéphan Haulon, MD, PhD

Purpose: To assess the displacement of the aorta and its visceral branch ostia after insertion of a rigid system including a stiff guidewire and endograft delivery system during endovascular aneurysm repair (EVAR).

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Back-Table Modification of a Bifurcated Infrarenal Stent-Graft to Aortomonoiliac for Emergencies

Nikolaos Tsilimparis, MD; Christina Lohrenz, MD; Axel Pflugradt, MD; Sabine Wipper, MD; Sebastian Debus, MD, PhD; Tilo Kölbel, MD, PhD

Purpose: To describe a simple and quick technique for converting a Zenith bifurcated stent-graft to an aortouni-iliac device for emergency treatment of hemorrhage when a suitable marketed stent-graft is not readily available.

01 febrero 2015

JOURNAL OF ENDOVASCULAR THERAPY. Impact of Renal Chimney Grafts on Anatomical Suitability for Endovascular Repair in Ruptured Abdominal Aortic Aneurysm

Nuno V. Dias, MD, PhD; Adel Bin Jabr, MD; Magnus Sveinsson, MD; Katarina Björses, MD, PhD; Martin Malina, MD, PhD; Thorarinn Kristmundsson, MD, PhD

Purpose: To evaluate the impact of renal chimney grafts on anatomical suitability for endovascular aneurysm repair (EVAR) in ruptured abdominal aortic aneurysm (rAAA).

01 febrero 2015

JOURNAL OF ENDOVASCULAR THERAPY. Infective Etiology Affects Outcomes of Late Open Conversion After Failed Endovascular Aneurysm Repair

Danilo Menna, MD; Laura Capoccia, MD, PhD; Pasqualino Sirignano, MD; Andrea Esposito, MD; Massimo Rossi, MD; Francesco Speziale, MD

Purpose: To retrospectively review all patients undergoing late open conversion (LOC) after endovascular aneurysm repair (EVAR) in order to identify any clinical or technical predictors of poor outcome.

01 febrero 2015

JOURNAL OF ENDOVASCULAR THERAPY. Vascular Response After Zilver PTX Stent Implantation for Superficial Femoral Artery Lesions

Yusuke Tomoi, MD; Shoichi Kuramitsu, MD; Yoshimitsu Soga, MD; Hideaki Aihara, MD; Kenji Ando, MD; Masakiyo Nobuyoshi, MD

Purpose: To compare the vascular response after paclitaxel-coated nitinol drug-eluting stent (Zilver PTX) implantation for superficial femoral artery lesions after 6 and 12 months using optical coherence tomography (OCT).

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Paclitaxel-Eluting Balloon vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: The DEBATE-ISR Study

Francesco Liistro, MD; Paolo Angioli, MD; Italo Porto, MD, PhD; Lucia Ricci, MD; Kenneth Ducci, MD; Simone Grotti, MD; Giovanni Falsini, MD; Giorgio Ventoruzzo, MD; Filippo Turini, MD; Guido Bellandi, MD; Leonardo Bolognese, MD

Purpose: To test the ability of a drug-eluting balloon (DEB) to reduce recurrent in-stent restenosis (ISR) in diabetic patients with femoropopliteal stents.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Percutaneous Transluminal Angioplasty With Drug-Eluting Balloons for Salvage of Infrainguinal Bypass Grafts

Enrique M. San Norberto, MD; James H. Taylor, MD; Santiago Carrera, MD; Carlos Vaquero, MD

Purpose: To evaluate the safety and feasibility of using drug-eluting balloons (DEBs) in the treatment of infrainguinal bypass graft stenoses.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Long-Term Outcomes of Endovascular Therapy for Aortoiliac Bifurcation Lesions in the Real-AI Registry

Hideaki Aihara, MD; Yoshimitsu Soga, MD; Osamu Iida, MD; Kenji Suzuki, MD; Junichi Tazaki, MD; Yoshiaki Shintani, MD; Yusuke Miyashita, MD

Purpose: To report long-term outcomes of endovascular therapy (EVT) for aortoiliac bifurcation lesions.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Nitinol Self-Expanding Stents vs. Balloon Angioplasty for Very Long Femoropopliteal Lesions

Ehrin J. Armstrong, MD, MSc; Haseeb Saeed, MD; Bejan Alvandi, BS; Satinder Singh, MD; Gagan D. Singh, MD; Khung Keong Yeo, MBBS; David Anderson, BA; Gregory G. Westin, BA; David L. Dawson, MD; William C. Pevec, MD; John R. Laird, MD

Purpose: To compare the patency rates and clinical outcomes of balloon angioplasty vs. nitinol stent placement for patients with short (≤150 mm) as compared to long (>150 mm) femoropopliteal (FP) occlusive lesions.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Early Recoil After Balloon Angioplasty of Tibial Artery Obstructions in Patients With Critical Limb Ischemia

Frederic Baumann, MD; Jacqueline Fust; Rolf Peter Engelberger, MD; Ulrike Hügel, MD; Do-Dai Do, MD; Torsten Willenberg, MD; Iris Baumgartner, MD; Nicolas Diehm, MD

Purpose: To assess the extent of early recoil in patients with critical limb ischemia (CLI) undergoing conventional tibial balloon angioplasty.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Photoablation Using the Turbo-Booster and Excimer Laser for In-Stent Restenosis Treatment: Twelve-Month Results From the PATENT Study

Andrej Schmidt, MD; Thomas Zeller, MD; Horst Sievert, MD; Hans Krankenberg, MD; Giovanni Torsello, MD; Matthew A. Stark, PhD; Dierk Scheinert, MD

Purpose: To evaluate the performance of the Turbo Elite laser catheter in combination with the Turbo-Booster guiding catheter for the treatment of femoropopliteal in-stent restenosis (ISR).